
    
      In comparison to EMLFO trial, the EMLFO-2 study will modify the eligibility criteria to only
      enroll the infants who have birthweight equal to or less than 1250 g with a jejunostomy or
      ileostomy as the result of surgical treatment for small intestine perforation or NEC in order
      to increase the homogeneity of patient population.
    
  